Literature DB >> 11801634

CD4 T cells selected by antigen under Th2 polarizing conditions favor an elongated TCR alpha chain complementarity-determining region 3.

Rosemary J Boyton1, Nathan Zaccai, E Yvonne Jones, Daniel M Altmann.   

Abstract

The affinity of the MHC/peptide/TCR interaction is thought to be one factor determining the differentiation of CD4+ T cells into Th1 or Th2 phenotypes. To study whether CD4+ cells generated under conditions favoring Th1 or Th2 responses select structurally different TCRs, Th1 and Th2 clones and lines were generated from nonobese diabetic and nonobese diabetic H2-E transgenic mice against the peptides proteolipoprotein 56-70, glutamic acid decarboxylase(65) 524-543, and heat shock protein-60 peptides 168-186 and 248-264. Th1/Th2 polarization allowed the generation of clones and lines with fixed peptide specificity and class II restriction but differing in Th1/Th2 phenotype in which the impact on TCR selection and structure could be studied. The Th2 clones tended to use longer TCR complementarity-determining region (CDR)3alpha loops than their Th1 counterparts. This trend was confirmed by analyzing TCRalpha transcripts from Th1 and Th2 polarized, bulk populations. Molecular modeling of Th1- and Th2-derived TCRs demonstrated that Th2 CDR3alpha comprised larger side chain residues than Th1 TCRs. The elongated, bulky Th2 CDR3alpha loops may be accommodated at the expense of less optimal interactions between the MHC class II/peptide and other CDR loops of the TCR. We propose that CD4+ T cells selected from the available repertoire under Th2 polarizing conditions tend to have elongated TCR CDR3alpha loops predicted to alter TCR binding, reducing contact at other interfaces and potentially leading to impeded TCR triggering.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801634     DOI: 10.4049/jimmunol.168.3.1018

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Recent thymic emigrants are biased against the T-helper type 1 and toward the T-helper type 2 effector lineage.

Authors:  Deborah W Hendricks; Pamela J Fink
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

2.  High-dose allergen exposure leads to tolerance.

Authors:  Judith A Woodfolk
Journal:  Clin Rev Allergy Immunol       Date:  2005-02       Impact factor: 8.667

Review 3.  Altered T-cell receptor signaling in the pathogenesis of allergic disease.

Authors:  Shrimati Datta; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

4.  T-cell-receptor-dependent signal intensity dominantly controls CD4(+) T cell polarization In Vivo.

Authors:  Nicholas van Panhuys; Frederick Klauschen; Ronald N Germain
Journal:  Immunity       Date:  2014-06-26       Impact factor: 31.745

5.  Revisiting thymic positive selection and the mature T cell repertoire for antigen.

Authors:  Nienke Vrisekoop; João P Monteiro; Judith N Mandl; Ronald N Germain
Journal:  Immunity       Date:  2014-08-21       Impact factor: 31.745

Review 6.  Organization of proximal signal initiation at the TCR:CD3 complex.

Authors:  Clifford S Guy; Dario A A Vignali
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

7.  CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire.

Authors:  Johan Verhagen; Raphaël Genolet; Graham J Britton; Brian J Stevenson; Catherine A Sabatos-Peyton; Julian Dyson; Immanuel F Luescher; David C Wraith
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

8.  Cutting edge: lack of high affinity competition for peptide in polyclonal CD4+ responses unmasks IL-4 production.

Authors:  Joshua D Milner; Nicolas Fazilleau; Michael McHeyzer-Williams; William Paul
Journal:  J Immunol       Date:  2010-05-21       Impact factor: 5.422

9.  Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile.

Authors:  Catherine Reynolds; Deborah Chong; Eleanor Raynsford; Kathryn Quigley; Deborah Kelly; Julia Llewellyn-Hughes; Daniel Altmann; Rosemary Boyton
Journal:  BMC Biol       Date:  2014-05-09       Impact factor: 7.431

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.